Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)
NCT00588588 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2023-09-26
Summary
The reported incidence of ventilator associated pneumonia (VAP) is 10 to 15 per 1,000 ventilator days. VAP leads to an excess cost exceeding $40,000 per patient and is associated with a crude mortality rate as high as 76%. The clinical criteria for the diagnosis of VAP have low specificity and may lead to unnecessary antibiotic use. The Clinical Pulmonary Infection Score (CPIS) and bronchoscopic approaches lower unnecessary antimicrobial use, antimicrobial resistance, and superinfection compared to the traditional clinical criteria.
Based on the available evidence and local microbiology data, we have developed a VAP management protocol guided by CPIS or bronchoalveolar lavage (BAL) in adults with suspected VAP. These two approaches have not been compared against each other. Although the diagnostic studies in the CPIS guided approach are inexpensive and easily available, BAL has the potential to minimize the unnecessary use of antibiotics and reduce the development of drug resistant pathogens.
In this study, we propose to test the hypothesis that BAL leads to a reduction in antibiotic use compared to CPIS in patients with suspected VAP. The study design will be a randomized, clinical trial comparing CPIS versus BAL. The primary outcome measure will be antibiotic utilization. The secondary outcome measures will be mortality, morbidity, development of resistant pathogens and superinfection and infection related financial burden.
Completion of this trial will help us identify the best approach to avoid unnecessary antibiotic utilization and minimize the development of resistant pathogens (with their associated morbidity and mortality) in critically ill patients.
Conditions
- Ventilator Associated Pneumonia
Interventions
- PROCEDURE
-
Bronchoscopy
Bronchoscopy procedure
- PROCEDURE
-
Clinical pulmonary infection score (CPIS)
Calculate CPIS
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Bekele Afessa, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2009-05-31
- Completion
- 2009-05-31
More Related Trials
-
Diagnostic Modalities for VAP Detection
NCT04911244 ·Status: COMPLETED ·Phase: NA
-
Effect of Selected Evidence-based Practices and Related Nurses' Education on the Incidence and Severity of Ventilator-associated Pneumonia
NCT05877105 ·Status: COMPLETED ·Phase: NA
-
Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation
NCT06072222 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Oropharyngeal Suctioning in Preventing Ventilator-Associated Pneumonia: A Randomized Controlled Trial.
NCT07128537 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostic Value of Pulmonary Ultrasound in the Diagnosis of Ventilator-associated Pneumoniae
NCT02536547 ·Status: COMPLETED
-
Pre-clinical Diagnosis Using Integrated Microbial and Host Response Signatures to Improve Outcomes From Ventilator-associated Pneumonia in Critically Ill Children
NCT07026656 ·Status: RECRUITING
-
Occurrence of Ventilator Associated Pneumonia in Italian ICU Using Cuffed Tracheostomy Tubes With Subglottic Secretion Drainage
NCT02223988 ·Status: COMPLETED ·Phase: NA
-
Fiberoptic Bronchoscopy in Severe Ventilator-associated Pneumonia
NCT07149909 ·Status: COMPLETED ·Phase: NA
-
Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia
NCT04563104 ·Status: COMPLETED
-
CDC Prevention Epicenters Wake Up and Breathe Collaborative
NCT01583413 ·Status: COMPLETED ·Phase: NA
-
Ventilator Associated Pneumonia by Multi-Drug Resistant Organism
NCT05549427 ·Status: COMPLETED
-
Risk Factors of Ventilator-Associated Pneumonia in Critically Ill Population of Alexandria
NCT07116382 ·Status: COMPLETED
-
Diagnosis of Ventilator- Associated Pneumonia in Children: A Comparative Study of Bronchoscopic and Non-Bronchoscopic Methods
NCT00495963 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy
NCT00529776 ·Status: COMPLETED ·Phase: NA
-
Air-impingement Manipulation to Clear Subglottic Secretion to Prevent VAP in Prolonged Intubated Patients
NCT02632539 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Leak-free Bronchoscope Adapter
NCT05288218 ·Status: WITHDRAWN ·Phase: NA
-
Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients
NCT02652247 ·Status: TERMINATED ·Phase: NA
-
Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation
NCT04553367 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection
NCT03041207 ·Status: COMPLETED
-
Biomarkers of Lung Injury With Low Tidal Volume Ventilation Compared With Airway Pressure Release Ventilation
NCT01038531 ·Status: TERMINATED ·Phase: NA
-
Ventilator Associated Tracheobronchitis in the First 14 Days in ICU
NCT01802827 ·Status: COMPLETED
-
Stability of Driving Pressure Changes During "Best Positive End Expiratory Pressure (PEEP)" Trial
NCT05958862 ·Status: WITHDRAWN
-
Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration
NCT02450825 ·Status: COMPLETED ·Phase: NA
-
Pleural Strain by Speckle-Tracking Ultrasound: Feasibility and Driving Pressure Associations
NCT06911450 ·Status: RECRUITING
-
Investigation of Compliance With Ventilator-Associated Pneumonia Prevention Methods and Incidence of Ventilator-Associated Pneumonia in Intensive Care Units
NCT04174274 ·Status: UNKNOWN